Clinical value of bile for the detection of mutant K-ras from colorectal liver metastases

Anticancer Research

Volumn 20, Issue 4, 2000, Pages 2469-2472

  De Kok, Jacques B ^a   Swinkels, Dorine W ^a   Ruers, Theo J M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Free DNA; Mutant allele specific amplification (MASA)

Indexed keywords

BUFFER; DNA; REAGENT;

ARTICLE; BILE; CANCER DIAGNOSIS; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EQUIPMENT; GENE MUTATION; HUMAN; LIVER METASTASIS; ONCOGENE K RAS; PRIORITY JOURNAL;

BILE; COLORECTAL NEOPLASMS; DNA, NEOPLASM; GENES, RAS; HUMANS; LIVER NEOPLASMS; MUTATION;

EID: 0033861360     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Williams NS, Northover JMA, Arnott SJ and Jass JR: Colorectal tumours. In: Oxford textbook of oncology. (Peckham M, Pinedo H, Veronesi U, eds). Oxford, Oxford University Press, 1995, Vol 1, pp 1135-1168.
2. Finlay IG and McArdle CS: Occult hepatic metastases in colorectal carcinoma. Br J Surg 73: 732-735, 1986.
3. Stone MD, Kane RA, Bothe A, Jessup JM, Cady B and Steele GD: Intraoperative ultrasound imaging of the liver at the time of colorectal cancer resection. Arch Surg 129: 431-436, 1994.
4. Leen E, Goldberg JA, Robertson J, Angerson WJ, Sutherland GR and Cooke TG et al: Early detection of occult colorectal hepatic metastases using duplex colour Doppler sonography. Br J Surg 80: 1249-1251, 1993.
5. Yeatman TJ, Bland KI, Copeland EM, Hollenbeck JI, Souba WW and Vogel SB et al: Relationship between colorectal liver metastases and CEA levels in gallbladder bile. Ann Surg 210: 505-512, 1989.
6. Abbruzzese JL, Evans DB, Raijman I, Larry L, King T and Leach SD et al: Detection of mutated c-Ki-ras in the bile of patients with pancreatic cancer. Anticancer Res 17: 795-801, 1997.
7. Sidransky D, Tokino T, Hamilton SR, Kinzler KW, Frost P and Vogelstein B et al: Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 256: 102-105, 1992.
8. Mao L, Hruban RH, Boyle JO, Tockman M and Sidransky D: Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res 54: 1634-1637, 1994.
9. Steiner G, Schoenberg MP, Linn JF, Mao L and Sidransky D: Detection of bladder cancer recurrence by microsatellite analysis of urine. Nat Med 3: 621-624, 1997.
10. de Kok JB, van Solinge WW, Ruers TJM, Roelofs RHWM, van Muijen GN and Willems JL, et al: Detection of tumour DNA in serum of colorectal cancer patients. Scand J Clin Lab Invest 57: 601-604, 1997.
11. Hasegawa Y, Takeda S, Ichii S, Koizumi K, Maruyama M and Fujii A, et al: Detection of K- ras mutations in DNAs isolated from feces of patients with colorectal tumors by mutant- allele-specific amplification (MASA). Oncogene 10: 1441-1445, 1995.
12. Forrester K, Almoguera C, Han K, Grizzle WE and Perucho M: Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 327: 298-303, 1987.
13. Oudejans JJ, Slebos RJC, Zoetmulder FAN, Mooi WJ and Rodenhuis S: Differential activation of ras genes by point mutation in human colon cancer with metastases to either lung or liver. Int J Cancer 49: 875-879, 1991.
14. Ajiki T, Onoyama H, Yamamoto M, Fujimori T, Maeda S and Saitoh Y: Detection of point mutations in K-ras gene at codon 12 in bile from percutaneous transhepatic choledochal drainage tubes for diagnosis of biliary strictures. Int J Pancreatol 18: 215-220, 1995.
15. Lee JG, Leung JW, Cotton PB, Layfield LJ and Mannon PJ: Diagnostic utility of K-ras mutational analysis on bile obtained by endoscopic retrograde cholangiopancreatography. Gastrointest Endosc 42: 317-320, 1995.